Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
Pratteln, Switzerland, November 29, 2022 – Santhera Pharmaceuticals (SIX: SANN) announces that its shareholders have approved all…
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.